Proper assembly of the class I heavy chain (HC), ~2-microglobulin (~2m), and peptide must occur in the endoplasmic reticulum (ER) in order for MHC class I molecules to be expressed on the cell surface. Newly synthesized class I HC bind calnexin, an ER resident chaperone. These calnexin-associated class I HC appeared to lack the stable association with ~2m in peptide transporter-deficient T2 cells since fl2m-unassociated class I HC-specific HC10 antibody, but not B2m-associated class I HC-specific W6/32 antibody, coimmunoprecipitated calnexin. To determine the precursor-product relationship of the pool of HC that bind peptide, class I-restricted peptides were added to lysates of T2 cells in vitro. These peptides stabilized preexisting/32m-associated HC complexes (~2m + :HC:pep-), but had no significant effect on the preexisting pool of calnexin-associated HC that lack ~2m. Release of HC from calncxin appeared to be controlled by the binding of ~2m, since B2m-deficient FO-1 ceils showed a prolonged association of class I HC with calnexin, while fl2m-transfected FO-1 cells displayed a more rapid dissociation of class I HC from calnexin. Consistent with this result, the dissociation of class I HC from calnexin did not appear to be dependent on peptide binding since the dissociation rates were similar in peptide transporter-deficient T2 cells and in wild-type T1 cells. From these observations, we speculate that in the stepwise assembly of class I molecules, calnexin may mediate dimerization of class I HC with fl2m, and that the unstable ~2m + :HC:pep-complexes, after dissociation from calnexin, subsequently bind peptide to complete the assembly.
M
HC class I molecules present peptide fragments of intracellular antigens to CD8 + cytotoxic T cells (1, 2) . Such endogenously synthesized proteins are proteolytically degraded into peptides in the cytoplasm and then are transported into the endoplasmic reticulum (ER 1) through an ER membrane-associated peptide (pep) transporter encoded by the TAP.1 and TAP.2 genes (3). The assembly of MHC class I heavy chains (HC), 32-microglobulin (32m), and peptides takes place in the ER (4) (5) (6) . Mutant cell lines that have defects in the assembly of MHC class I molecules, such as fl2m-defldent cell lines (R1E in mouse and Daudi in human), lack cell surface expression of MHC class I molecules (7, 8) . Similarly, mice with disruption of the ~zm gene express no MHC class I molecules and display a profound defect in CD8 § T cell development (9, 10) . In addition, mutant cell lines that have deleted the peptide transporter (such as RMA-S and .174/T2 cells) appear unable to load peptides onto MHC class I molecules in the ER (11) (12) (13) and also have a severe defect in the expression of MHC class I molecules on the 1 Abbreviations used in this paper: Bzm, 32-microglobulin; ER, endoplasmic reticulum; HC, MHC class I heavy chain; pep, peptide. cell surface. Thus, the complete assembly of MHC class I molecules in the ER is an essential step for their cell surface expression.
Studies on the assembly of class I molecules have suggested alternative stepwise sequences (14, 15) . In one proposed pathway, the HC can form a loose association with fl2m, which is then stabilized by peptide occupying the binding site. Alternatively, a short, high-affinity peptide might stabilize a conformational change of the HC, which can then associate with B2m (16) . In either case, the binding of peptide and ~2m to the HC is cooperative, and peptide binding like the association with B2m is an inherent component of class I assembly. Although recombinant or purified components of class I HCs, B2m, and synthesized specific peptides can assembly in in vitro buffer systems, such assembly requires high concentrations of each component and long periods of time to occur (17, 18) . Recent evidence has implied that, in vivo, molecular chaperones may facilitate protein folding and assembly (19) , and this may be physiologically relevant for class I assembly in the ER. Calnexin (IP90, p88) was identified as an ER resident protein that associates with incompletely assembled TCR/CD3, membrane Ig, and MHC class I complexes (20) (21) (22) or with incompletely folded secretory glycoproteins (23) in the ER. Calnexin associates with free class I HCs soon after their synthesis, but this association is transient and calnexin dissociates from completely assembled class I complexes (24, 25) . Thus, calnexin has been hypothesized to play a role in facilitating class I assembly and in mediating retention of incompletely assembled complexes in the ER (26, 27) .
In the present study, we characterize a pool of calnexinassociated class I HCs, and delineate a possible stepwise sequence of class I assembly.
Materials and Methods
Cells, Antibodies, andPeptides. T2 and T1 cell lines (28) and T2 cells transfected with HLA-B27 (T2/B27) (13) were provided by Dr. Peter Cresswell (Yale University, New Haven, CT). These ceil lines were cultured in RPMI 1640 (GIBCO BRL, Gaithersburg, MD) supplemented with 10% heat-inactivated FCS (Hyclone Laboratories, Logan, UT), 20 mM Hepes, 2 mM glutamine, and 1 mM pyruvate (all from GIBCO BILL) at 37~ in a 5% CO2 atmosphere. B2m-deficient FO-1 cells (29) were provided by Dr. Soldano Ferrone (New York Medical Coflege, Valhalla, NY). 3zm-expressing and mock transfectant clones of FO-1 cells were obtained from transfection of either pb2m13 (30) plus pSRoe-neo (31) or pSRot-neo alone, respectively, by calcium phosphate precipitation method (32) . These transfectant clones were grown in DMEM supplemented with 10% FCS in the presence of 0.5 rag/m1 G418 (Geneticin; Sigma Chemical Co., St. Louis, MO). mAbs W6/32 (specific for 32m + :HC; IgG2a) (33), L243 (anti-HLA-DR antibody; IgG2a) (34) , and P3 (negative control; IgG1) (35) were obtained from the American Type Culture Coflection (Rockville, MD). mAb HC-10 (IgG2a) which recognizes B2m-:HC, but not Bzm + :HC (36) was provided by Dr. Hidde Ploegh (Massachusetts Institute of Technology, Cambridge, MA). Anti-calnexin/IP90 antibody, AF8 (IgG1), was generated in our laboratory (20) . UPC10 is a negative control antibody (IgG2a) purchased from Sigma Chemical Co. M57-68K62 peptide (14) which binds to HLA-A2.1 was synthesized with a peptide synthesizer (model 430A; Applied Biosystems Inc., Foster City, CA) at the core biopolymer laboratory, Brigham and Women's Hospital. HLA-B27-restricted B27NP peptide (18) was a gift from Dr. William E. Biddison (National Institutes of Health, Bethesda, MD).
Intracelhlar Iodination. Intracellular iodination was performed as described (20) . Briefly, T2 cells (4 x 107) were permeabilized in 8 pM digitonin (Aldrich Chemical Co., Milwaukee, WI) for 5 min. After lactoperoxidase-mediated iodination of permeabilized T2 cells, they were sohbilized in 1% digitonin in lysis buffer (140 mM NaC1, 50 mM Tris (pH 7.6), 7.5 mM iodoacetamide, and 1 mM PMSF). Immunoprecipitations with indicated mAbs were analyzed on a SDS-PAGE gel under reducing conditions and visualized by autoradiography on Kodak XAR film.
In Vitro Peptide-dependent Assembly. After 1 h preincubation in methionine-free RPMI 1640 media, 107 cells/ml were labeled for 5 min with 0.2 mCi [3SS]methionine (NEG-072 EXPRE3ZS32S; Du Pont Co., Boston, MA). Cells were lysed in 0.5% Triton X-100 in lysis buffer either in the presence or absence ofpeptides. After 20 rain at 4~ the nuclei were removed by centrifugation and the lysates were precleared overnight at 4~ with Staphylococcus aureus Cowan strain I (Pansorbin; Calbiochem-Novabiochem Corp., La Jolla, CA). Assembled class I molecules were detected with 1 pl of mAb W6/32 ascites, followed by immunoprecipitation with 50 /zl of 10% protein A-Sepharose CD4B (Pharmacia, Piscataway, NJ).
Pellets were washed four times with 0.5% Triton X-100 in Trisbuffered saline. The samples were analyzed on a SDS-PAGE gel under reducing conditions or, in some experiments, on IEF/SDS-PAGE two-dimensional gels as described (21) . The gels were fluorographed using PPO(2.5-diphenyloxazole)-DMSO (Du Pont Co.), dried, and exposed to Kodak XAR film.
Rapid Immunoprecipitation. T1 and T2 cells were biosynthetically labeled with [3SS]methionine for 5 min as described above. Cells were then solubilized in 0.5% Triton X-100 in lysis buffer containing mAb UPC10 (2 /~g/ml), mAbs W6/32, or HC10 (1:1,000 dilution of ascites). After 15 min at 4~ the nuclei were removed by centrifugation and the lysates were incubated with protein A-Sepharose CI.-4B (Pharmacia) for 30 min. The beads were washed four times with 0.1% Triton X-100 in Tris-buffered saline and boiled in sample buffer. All the procedures before electrophoresis were completed at 4~ within 2 h.
Pulse Chase Experiments.
Pulse chase experiments were performed as described (21) (20) . To examine whether 32m-:HC also were bound to calnexin in peptide transporter-deficient T2 cells, we carried out iodination of intraceUuhr proteins using a permeabilized ceU iodination technique. As an abundant ER protein, calnexin was visualized prominently by this method (Fig. 1, lane 2) . The HC10 antibody coimmunopt~zipitated calnexin with B2m-:HC from iodinated T2 calls (Fig. 1, lane 3) , demonstrating the association of calnexin with class I HCs that had not assembled with B2m. Note that in contrast to the HC10 antibody, a comformation-dependent antibody, W6/32, which recognizes 32m+:HC, failed to coimmunoprecipitate calnexin (Fig. 1, lane 4) . This implied that calnexin bound B2m-:HC, but not 32m + :HC. This led us to assume that there may be several distinct intraceUular class I HC pools, including B2m-unassociated HCs (B2m + :HC) either bound to calnexin or not, and B2m-associated HCs (32m + :HC) which may contain a bound peptide (32m + :HC:pep +) or not (32m+: HC:pep-) (Fig. 2) .
The 32m-:HC pool associated with calnexin was not readily visualized by iodination (Fig. 1, lane 2) . This pool was more efficiently identified by coimmunoprecipitation with calnexin when T2 cells were pulse-labeled biosynthetically with [3SS]methionine for 5 min. mAb AF8 immunoprecipitated calnexin (Fig. 3 A, lane 1, arrow) , and also coimmunoprecipitated a number of other proteins. A band was observed in lane I (arrowhead) that comigrated with class I HCs immunoprecipitated with mAb HC10 (lane 2). It was confirmed by IEF/SDS-PAGE two-dimensional gel analysis that most of the proteins contained in this band were mAb HC10-reactive class I HCs (Fig. 3 B) . The efficient visualization of dass I HCs associated with calnexin by biosynthetically pulse labeling cells implied that calnexin bound preferentially newly synthesized class I HCs. However, in the reciprocal immunoprecipitation the calnexin band was faintly visualized in the immunoprecipitation with mAb HC10 (Fig. 3 A, lane 2) , since in this 5-rain biosynthetic labeling only a small fraction of calnexin molecules, which have a half-life of >24 h (data not shown), were labeled. We infer that the major portion of 32m-:HC-associated calnexin molecules are from a pool of preexisting, unlabeled calnexin molecules, since 32m-:HC-associated calnexin molecules were readily detected after permeabilized iodination which labels all calnexin molecules (Fig. 1, lane 3 (Fig. 3 A, compare lanes 3 and 6). The faint but significant immunoprecipitation of class I HCs with mAb W6/32 in the absence of peptides (Fig. 3 A, lane 3) may be due either to assembled t-ILA-A2 molecules which bound peptides derived from signal sequences (38, 39) or to a small quantity of/32m + :HC:pepcomplexes.
Despite the abundant appearance of W6/32 reactive class I complexes (Fig. 3 A, lane 6) , neither the HC10-reactive B2m-:HC pool (lanes 2 and 5) nor the calnexin-associated ~2m-:HC pool of class I molecules (lanes I and 4) appeared to diminish after the addition of peptides. The absence of change in these B2m-:HC pools by the addition of peptides led us to speculate that in this in vitro peptide-dependent assembly system, ~2m-:HC, either bound to calnexin or not, were not the direct precursors of the class I complexes being assembled.
Unstable ~2m + :HC:pep -Complexes Are Present in T1 and T2 Cells. Several studies have shown that in this in vitro peptide-dependent class I assembly system, unstable ~2m + : HC:pep-complexes could be stabilized in detergent by the addition of specific peptide (14, 15, 37, 40) . We confirmed the presence of these unstable complexes in mutant T2 cells and wild-type T1 cells by comparing rapid immunoprecipiration with regular immunoprecipitation (see Materials and Methods). With the rapid immunoprecipitation method, a large pool of W6/32-reactive, B2m + :HC complexes could be detected even without the addition of peptide in peptidedeficient T2 cells (Fig. 4, lane 8) . On the other hand, when exactly the same procedure was carried out, except that mAb W6/32 was added after overnight incubation of the lysate at 4~ remarkably fewer/32m+:HC complexes were de- tected by the antibody (Fig. 4, lane 11) . Correspondingly, more ~/2m-:HC was detected with mAb HC10 than in the rapid immunoprecipitation. Since these experiments were performed in the absence of added peptides, we concluded that a substantial pool of j82m + :HC:pep-complexes were generated in T2 cells and were recognized by mAb W6/32, but that these complexes were unstable and presumably disassembled during the overnight incubation at 4~
Wild-type T1 cells, which have not deleted the TAP.1 and TAP.2 genes, have apparently normal class I assembly. Unlike T2 cell lysates, T1 cell lysates, which contain a substantial pool of completely asgembled class I molecules, still contained substantial quantities of W6/32-reactive class I molecules after overnight incubation (Fig. 4, lane 5) . However, a significant reduction in ~2m-:HC immunoprecipitated with mAb W6/32 and an increase in ~/2m-:HC immunoprecipitated with mAb HC10 were observed after overnight incubation even in T1 cells (Fig. 4, compare lanes 2 and 5,  and lanes 3 and 6) . Since a greater quantity of W6/32-reactive class I molecules were detected by rapid immunoprecipitation compared to after an overnight incubation, we concluded that relatively unstable B2m + :HC complexes were generated not only in peptide transporter deficient mutant cells but also in normal cells, as suggested by others (14, 15, 40 (Fig. 5 A) . As expected, in T1 cells, the HC10-reactive 32m-:HC pool decreased and a large amount of W6/32-reactive class I molecules were detected during a chase period, consistent with normal MHC class I assembly. In contrast, in T2 cells the total amount of 32m-:HC pool remained almost unchanged during the chase period and a much smaller amount of assembled class I molecules were observed, consistent with a deficiency in peptides in the ER lumen of these cells. It is important to note that the association of class I HCs with calnexin diminished during the chase period of time in both T1 and T2 cells, and that the rate of dissociation was almost indistinguishable between the two call lines despite the difference in availability of peptides in the ER of these two cell lines (Fig. 5 C, left) .
To address the possibility that B2m controls the rates of dissociation of class I HCs from calnexin, we examined 32m + and 32m-cells. For comparison with 32m-deficient FO-1 cells (FO-1 mock) , we transfected the 32m genomic DNA clone and reconstituted 32m expression in FO1 cells (FO-1 32m) . In contrast to the observation of peptidedeficient cells above, a significant difference in dissociation of class I HCs from calnexin in vivo was found between ~2m-deficient FO-1 mock and ~2m-expressing FO-1 32m cells. In FO-1 ~82m cells, a decrease in the HC10-reactive B2m-:HC pool and the appearance of the W6/32-reactive B2m+:HC pool was observed during the chase period, whereas in ~2m-deficient FO-1 mock cells, the total amount of/32m-:HC pool remained almost unchanged and no appearance of the W6/32-reactive ~/2m+:HC pool was seen (Fig. 5 B) . More importantly, the association of class I HCs with calnexin diminished during the chase period in FO-1 B2m cells, whereas class I HCs remained associated with calnexin in the A82m-deficient FO-1 mock cells (Fig. 5, B and 
C, right).

Discussion
In order for class I molecules to complete their assembly and exit the ER, at least three events should take place in the ER; namely, binding of Barn to class I HC, binding of peptide to class I HC, and dissociation of class I HC from calnexin. The former two are critically important for proper expression of class I molecules because lack of either 32m or peptide has been shown to result in severely impaired class I expression (7) (8) (9) (10) (11) . Properly regulated dissociation of class I HCs from calnexin seems also essential since class I HCs are retained in the ER by calnexin in the absence of 32m (24, 41) . In the present study, we describe the stepwise sequence of these events.
One of the important approaches of this study was to discriminate intracellular class I HC pools in terms of association either with ~32m or with calnexin and to assess changes in these pools during peptide-dependent class I assembly (or stabilization) in cell lysates. The interaction of nascent class I HCs with calnexin occurs very soon after their synthesis (possibly cotranslationally or cotranslocationally) (21, 22) . Thus, employing 5 min short pulse labeling with [3SS]methionine made it possible to visualize a pool of calnexinassociated class I HCs in immunoprecipitates with an anticalnexin antibody (Fig. 3 A, lane 1) . Class I HCs in this pool appeared to be /52m-unassociated since calnexin was coimmunoprecipitated with mAb HC10, which recognizes 32m-:HC, but not with W6/32, which recognizes 32m+: HC (Fig. 1) .
The addition of specific peptides upon lysis of peptide transporter-deficient cell lines has been shown to stabilize 32m + : HC:pep-in detergent (14, 15, 37, 40) , which is manifested by an increase in the amount of 32m + :HC immunoprecipitated. In our experiments, we used T2/B27 cells expressing both endogenous HLA-A2 and transfected -B27 HCs. As expected, the addition of HLA-A2 and -B27 restricted peptides resulted in a significant increase in W6/32-reactive class I HC complexes (Fig. 3, lane 6) . However, the detectable pool of calnexin-associated class I HCs did not appear to diminish despite the abundant appearance of assembled class I complexes (Fig. 3) . This is consistent with the above observation that calnexin-bound class I HCs are unassociated with 32m since these peptide addition experiments preferentially detect stabilizing effect of peptide on unstable 32m + :HC: pep-complexes.
The presence of unstable B2m + :HC:pep-complexes which are not bound to calnexin in normal cells and the finding that calnexin binds 32m-:HC led us to speculate that the dissociation of class I HCs from calnexin might be controlled by binding of ~2m. Previous work has implied that newly synthesized class I HCs are retained for a prolonged period of time in association with calnexin in 32m-deficient Daudi cells (24, 41) , which implied a requirement for 32m for the dissociation of class I HCs from calnexin. We confirmed this by comparing 32m-deficient FO-1 cells, which showed a prolonged association of class I HCs with calnexin, with 32m transfected FO-1 cells, which displayed more rapid dissociation of class I HCs from calnexin (Fig. 5 B) . In contrast, class I HCs did not show a prolonged association with calnexin in T2 cells in which peptides are not available but 32m is present (Fig. 5 A) . Class I HCs dissociated from calnexin in T2 cells at a similar rate as in wild-type T1 cells (Fig. 5  C) , implying that peptide binding was not required for class I HCs to dissociate from calnexin. These conclusions are strengthened by the recent demonstration that calnexin-free 32m+:HC:pep -complexes physically associate with TAP molecules in human (42) . These results are in contrast with studies of mouse p88/calnexin, in which a requirement for both 32m and peptide for the dissociation of class I HCs from calnexin was detected (24) and murine 32m + :HC:pepcomplexes were efficiently retained by p88/calnexin when expressed in Drosophila cells (26) . Although the reason for this apparent disparity is not known, the difference might be explained by variable behavior of subtypes of class I molecules from the different species examined. Species-specific differences in MHC class I assembly and transport have been noted previously, as in the report that mouse class I molecules expressed in RMA-S and T2 cells behave differently from human class I molecules in these cell lines, presumably due to fundamental structural differences of the class I glycoproteins between species (43) .
From the observations above, we propose an in vivo pathway for class I assembly (Fig. 6 ). Newly synthesized class I HCs bind to calnexin which retains them in the ER (HC-calnexin). Subsequently, the association of 32m occurs to form a transient trimolecular complex of HC, 32m, and calnexin (shown within parentheses). Calnexin then dissociates from 32m-associated HCs (HC-32m) and finally, these unstable peptide-free class I complexes bind peptide to complete the assembly process and stabilize the MHC class I complexes. Thus, calnexin mediates retention of the ~2m-unassociated class I HCs and dimerization of class I HCs with B2m, and the final step of peptide loading onto 32m + :HC:pep-complexes may be facilitated by physical association of these class I complexes with TAP molecules, as suggested by Cresswell and colleagues (42) . It remains to be clarified if TAP molecules exist in close approximation to calnexin and by what mechanisms 32m + :HC:pep-complexes can bind to and dissociate from TAP molecules.
We thank Drs. Peter Cresswell and Soldano Ferrone for the gift of cell lines, Dr. Hidde Ploegh for the We thank Drs. Peter Cresswell and Soldano Ferrone for the gift of cell lines, Dr. Hidde Ploegh for the
